Rachel Humphrey

Director, Pyxis Oncology, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.0M

Companies

Latest trade

Apr 21, 2025

Companies

Pyxis Oncology, Inc.Director −$0.0M

Trades

PYXS Sold 13,896 shares at $1.03 · planned $0.0M Apr 21

PYXS Sold 200 shares at $0.97 · planned $0.0M Apr 17

PYXS Sold 1,400 shares at $0.97 · planned $0.0M Apr 14

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.